BJC Capital Advisors Granted FINRA Membership

• designates firm as SEC registered broker/dealer
• expands services to include securities-related transaction
• differentiated suite of capabilities integrates with core needs of early-stage life science companies

 
We are pleased to announce that last week we received notification from FINRA that our application for membership has been approved.  Approval of the application, the culmination of a nearly ten-month process, formally designates the firm as a registered broker/dealer allowing us to participate in regulated securities transactions.  FINRA membership extends the services we are able to provide earlier-stage life science companies to include private equity placements and transaction advisory services, including licensing, strategic partnerships and alliances, and mergers & acquisitions engagements, where we participate on both buy-side and sell-side engagements.  These capabilities build upon decades of prior investment banking, strategy consulting and corporate management experience.

Differentiating our transaction business are a range of complementary services that are offered in conjunction with Danforth Advisors and tailored primarily to the needs of emerging stage biopharmaceutical companies, including a chief medical officer executive network that provides access to distinguished senior-level talent on an interim or fractional basis and our IPO preparation services, where we work closely with company management to draft a compelling and thoughtful business section for S-1, F-1 and certain S-4 filings.  We believe the seamless integration of this suite of capabilities addresses needs central to our clients’ success.

member FINRA/SIPC